Servet Bölükbas

发表

Pneumonectomy vs. Sleeve Resection for Non-Small Cell Lung Carcinoma in the Elderly: Analysis of Short-term and Long-term Results

S. Bölükbas, M. Eberlein, J. Schirren, 2011, The Thoracic and cardiovascular surgeon.

Diagnostic Gain from Surgical Biopsy for Interstitial Lung Disease – When is it Worth the Risk?

S. Bölükbas, I. Bittmann, D. Kirsten, 2016, Pneumologie.

LIONS PREY: A New Logistic Scoring System for the Prediction of Malignant Pulmonary Nodules

G. Schlachtenberger, Khosro Hekmat, Hruy Menghesha, 2024, Cancers.

ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma

F. Galateau-Sallé, V. Durieux, P. V. Van Schil, 2020, European Respiratory Journal.

Krebs von den Lungen 6 (KL-6) is a novel diagnostic and prognostic biomarker in pleural mesothelioma.

C. Pirker, B. Hegedüs, C. Blanquart, 2023, Lung cancer.

C-reactive protein as robust laboratory value associated with prognosis in patients with stage III non-small cell lung cancer (NSCLC) treated with definitive radiochemotherapy

M. Wiesweg, N. Guberina, M. Guberina, 2024, Scientific reports.

Long-Term Survival in Patients with Oligometastatic Non-Small Cell Lung Cancer by a Multimodality Treatment—Comparison with Stage III Disease

T. Gauler, M. Wiesweg, N. Guberina, 2024, Cancers.

ERASURE: early autologous blood pleurodesis for postoperative air leaks—a randomized, controlled trial comparing prophylactic autologous blood pleurodesis versus standard watch and wait treatment for postoperative air leaks following thoracoscopic anatomic lung resections

E. Roessner, Bogdan Vidmar, Servet Bölükbas, 2024, Trials.

Closing the RCT Gap—A Large Meta-Analysis on the Role of Surgery in Stage I–III Small Cell Lung Cancer Patients

G. Schlachtenberger, M. Michel, Khosro Hekmat, 2024, Cancers.